Funding for this research was provided by:
National Natural Science Foundation of China (82072597)
Beijing Xisike Clinical Oncology Research Foundation (No. Y-XD2019-214, No. Y-2019Roche-149)
Article History
Received: 10 September 2021
Accepted: 20 March 2022
First Online: 1 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.